NorthView Acquisition Corporation (NVAC)
$10.78
-0.01 (0.00%)
Rating:
Recommendation:
-
| Symbol | NVAC |
|---|---|
| Price | $10.78 |
| Beta | 0.000 |
| Volume Avg. | 0.00M |
| Market Cap | 66.490M |
| Shares () | - |
| 52 Week Range | 9.92-10.79 |
| 1y Target Est | - |
| DCF Unlevered | NVAC DCF -> | |
|---|---|---|
| DCF Levered | NVAC LDCF -> | |
| ROE | 3.54% | Neutral |
| ROA | 32.48% | Strong Buy |
| Operating Margin | - | |
| Debt / Equity | 4.14% | Neutral |
| P/E | 56.74 | Strong Buy |
| P/B | 7.46 | Strong Buy |
About
Download (Excel)NorthView Acquisition Corporation does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to focus its search on businesses that are focused on healthcare sector. The company was incorporated in 2021 and is based in New York, New York. NorthView Acquisition Corporation is a subsidiary of NorthView Sponsor I, LLC.